Cargando…

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model

BTZ-043, a suicide inhibitor of the Mycobacterium tuberculosis cell wall synthesis decaprenylphosphoryl-beta-D-ribose 2′ epimerase, is under clinical development as a potential new anti-tuberculosis agent. BTZ-043 is potent and bactericidal in vitro but has limited activity against non-growing bacil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramey, Michelle E., Kaya, Firat, Bauman, Allison A., Massoudi, Lisa M., Sarathy, Jansy P., Zimmerman, Matthew D., Scott, Dashick W. L., Job, Alyx M., Miller-Dawson, Jake A., Podell, Brendan K., Lyons, Michael A., Dartois, Véronique, Lenaerts, Anne J., Robertson, Gregory T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648937/ https://www.ncbi.nlm.nih.gov/pubmed/37791784 http://dx.doi.org/10.1128/aac.00597-23

Ejemplares similares

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
por: Robertson, Gregory T., et al.
Publicado: (2021)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015)

Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
por: Lanoix, Jean-Philippe, et al.
Publicado: (2015)

In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis
por: González-Martínez, Norma Alejandra, et al.
Publicado: (2015)

Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
por: Irwin, Scott M., et al.
Publicado: (2016)

Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018)

In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice
por: Gautam, Uma Shankar, et al.
Publicado: (2015)

Mycobacterium avium Infection in a C3HeB/FeJ Mouse Model
por: Verma, Deepshikha, et al.
Publicado: (2019)

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
por: Liu, Renhe, et al.
Publicado: (2017)

Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
por: Chhabra, Sonali, et al.
Publicado: (2021)

Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
por: Xiang, Wang, et al.
Publicado: (2023)

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)

Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
por: Batt, Sarah M., et al.
Publicado: (2023)

Catheter-associated Mycobacterium intracellulare biofilm infection in C3HeB/FeJ mice
por: Yamamoto, Kentaro, et al.
Publicado: (2023)

Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
por: Chikhale, Rupesh V, et al.
Publicado: (2014)

Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
por: Wang, Pengxu, et al.
Publicado: (2021)

Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
por: Irwin, Scott M., et al.
Publicado: (2015)

Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Temporal analysis of mRNA expression profiles in Orientia infected C3HeB/FeJ mouse
por: Chao, Chien-Chung, et al.
Publicado: (2020)

Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model
por: Robertson, Gregory T., et al.
Publicado: (2019)

OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
por: Hariguchi, Norimitsu, et al.
Publicado: (2020)

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents
por: Yadav, Veena D., et al.
Publicado: (2023)

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
por: Piton, Jérémie, et al.
Publicado: (2018)

Oral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice
por: Cardona, Paula, et al.
Publicado: (2016)

Influence of Gut Microbiota on Progression to Tuberculosis Generated by High Fat Diet-Induced Obesity in C3HeB/FeJ Mice
por: Arias, Lilibeth, et al.
Publicado: (2019)

Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools
por: Mali, Suraj N., et al.
Publicado: (2022)

The C3HeB/FeJ mouse model recapitulates the hallmark of bovine tuberculosis lung lesions following Mycobacterium bovis aerogenous infection
por: Bouté, Mélodie, et al.
Publicado: (2017)

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
por: Walter, Nicholas D., et al.
Publicado: (2023)

Longer-Term Omega-3 LCPUFA More Effective Adjunct Therapy for Tuberculosis Than Ibuprofen in a C3HeB/FeJ Tuberculosis Mouse Model
por: Hayford, Frank E. A., et al.
Publicado: (2021)

Polyamines Inhibit Porin-Mediated Fluoroquinolone Uptake in Mycobacteria
por: Sarathy, Jansy Passiflora, et al.
Publicado: (2013)

Fermionic Corrections to Fluid Dynamics from BTZ Black Hole
por: Gentile, L.G.C., et al.
Publicado: (2013)

The HEB at flat top: arranging for the HEB to collider beam transfer
por: Larson, D J
Publicado: (1994)

Photochemistry of Ru(II) 4,4′-Bi-1,2,3-triazolyl (btz) Complexes: Crystallographic Characterization of the Photoreactive Ligand-Loss Intermediate trans-[Ru(bpy)(κ(2)-btz)(κ(1)-btz)(NCMe)](2+)
por: Welby, Christine E, et al.
Publicado: (2014)

On-Slide Heat Sterilization Enables Mass Spectrometry Imaging of Tissue Infected with High-Threat Pathogens Outside of Biocontainment: A Study Directed at Mycobacterium tuberculosis
por: Wang, Ning, et al.
Publicado: (2021)

Spatial multiomic profiling reveals the novel polarization of foamy macrophages within necrotic granulomatous lesions developed in lungs of C3HeB/FeJ mice infected with Mycobacterium tuberculosis
por: Seto, Shintaro, et al.
Publicado: (2022)

The Role of Transport Mechanisms in Mycobacterium Tuberculosis Drug Resistance and Tolerance
por: Sarathy, Jansy Passiflora, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_t9vh44thi22md5sr16danaobqg